WIF1 and systemic sclerosis: TSA administered in bleomycin-treated mice stopped ECM accumulation in the skin [133], as well as efficacy in downregulating fibrotic-related genes, such as COL and Wnt inhibitor WIF1, in dermal fibroblasts isolated from SSc patients [115,133].